Skip to content
CancerIndex

Publication

Association between ABCB1 genetic polymorphisms with treatment outcomes in patients with metastatic pancreatic cancer.

Masahiro Hatori, Rei Arafune, Kenichi Suzuki, Takashi Yokokawa, Kazuyoshi Kawakami, Eiji Nakatani, Masahiko Nakao, Takuya Yano, Yuichiro Arakawa, Naoki Sasahira, Masato Ozaka, Hiroshi Ishii, Masakazu Yamaguchi, Kunihiko Itoh, Daiki Tsuji

International journal of clinical oncologySep 19, 2026PMID 42762424doi:10.1007/s10147-026-03201-0 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 26, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260926-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

BACKGROUND: Gemcitabine plus nanoparticle albumin-bound-paclitaxel (GnP) therapy cause sometimes severe neutropenia in all the treatment period, which was reported to association with overall survival (OS). However, the relationship between pharmacokinetics-related genetic polymorphisms and both OS…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.